AQR Capital Management
ADMS

AQR Capital Management’s Adamas Pharmaceuticals ADMS Stock Holding History

AQR Capital Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-420,304
Closed -$1.08M – 2308
2020
Q2 		$1.08M Buy
420,304
+203,582
+94% +$598K ﹤0.01% 1435
2020
Q1 		$626K Buy
216,722
+169,014
+354% +$757K ﹤0.01% 1508
2019
Q4 		$181K Buy
+47,708
New +$228K ﹤0.01% 2022
2018
Q4 		– Sell
-14,897
Closed -$298K – 2317
2018
Q3 		$298K Sell
14,897
-917
-6% -$21.5K ﹤0.01% 2110
2018
Q2 		$408K Buy
15,814
+3,310
+26% +$91.7K ﹤0.01% 2046
2018
Q1 		$299K Buy
12,504
+3,329
+36% +$105K ﹤0.01% 2048
2017
Q4 		$311K Buy
+9,175
New +$256K ﹤0.01% 2059
2016
Q1 		– Sell
-9,964
Closed -$282K – 2311
2015
Q4 		$282K Buy
+9,964
New +$168K ﹤0.01% 2054

Other funds holding ADMS

AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return